International Conference on Cell & Stem Cell Research
Combating COVID-19 with Stem Cells
The world was astonished when a new coronavirus respiratory disease (COVID-19) caused by the SARS-CoV-2 virus emerged, causing social, economic, and health concerns. Since its discovery, various biomedical professionals from around the world have been mobilizing to find a therapy to contain this pandemic infection. As a result, the latest COVID-19 outbreak emphasizes the critical need for safe and effective treatments, particularly for the most severe patients. For regenerative medicine and cellular therapy, stem cells have always been a hot topic. The importance of stem cells in modern medicine is undeniable, both for their application in basic research and for the potential to produce novel medicines in clinical practice. Because of the need of developing innovative and effective treatments for COVID-19, stem cells have taken a prominent role in the scene. Stem cells produced from the amnion of the human placenta, in particular, should be investigated for the treatment of this type of pulmonary diseases, as well as a wide spectrum of disorders, due to their immunoregulatory, reparative, and regenerative qualities.
- Stem Cell Therapy For COVID-19
- Stem Cell Therapy In COVID-19 Respiratory Distress
- Mesenchymal Stem Cells (MSCs)
Roberto Gramignoli
Karolinska Institutet, Sweden
P K Prem Ravi Varma
Cancer Research Centre, India
Federico Carpi
University of Florence, Italy
Pushpam Kumar Sinha
Independent Researcher, India
Alessandra Salvetti
University of Pisa, Italy
Ahmed G Hegazi
National Research Center, Egypt
Gulay Sezer
Erciyes University, Turkey
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Liver cell therapies: From hepatocyte transplant to placental stem cell infusion
Roberto Gramignoli, Karolinska Institutet, Sweden
Title : The common cure for all cancers- clue from cancer stem cells
Pushpam Kumar Sinha, Independent Researcher, India
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Stem cell-induced proliferation on the hippocampus after intranasal administration of Galanin receptor 2 and neuropeptide Y1 receptor agonists: Role in spatial memory and depression-like effects in rats
Manuel Narvaez Pelaez, Malaga University, Spain
Title : Msc-exosomes in osteoarthritis treatment
Neus Figa Martin, Clínica Exolife, Spain